Table 2 Comparison of three study period values and difference of each period within and between clinics
Site | Study Implementation Period Value | Study Steady State Period Value | Difference of Steady State and Implementation within each site (p value)d | Chart Intervention Period Value | Difference of Intervention and Steady State within each site (p value)d | Difference of Intervention and Implementation within each sites (p value)d | |
|---|---|---|---|---|---|---|---|
Viral Suppressiona | Bethesda CDC | 59·2% | 74·7% | 15·5% (0·022) | 68·5%c | −6·2% (0·42) | 9·3% (0·12) |
RK Khan (ref) | 62·3% | 76·2% | 13·8% (0·036) | 80·9% | 4·7% (0·01) | 18·6% (< 0·01) | |
Mkhuze | 31·2%c | 59·5%c | 28·3% (< 0·01) | 70·5%c | 10·9% (< 0·01) | 39·3% (< 0·01) | |
Shallcross (ref) | 69·4% | 84·1% | 14·7% (< 0·01) | 85·4% | 1·3% (0·49) | 16·0% (0·04) | |
Jozini | 32·6%c | 61·8% | 29·2% (< 0·01) | 68·8%c | 7·0% (0·48) | 36·2% (< 0·01) | |
Township (ref) | 51·5% | 62·3% | 10·8% (< 0·01) | 62·9% | 0·7% (0·69) | 11·4% (< 0·01) | |
Viral Load Test Performedb | Bethesda CDC | 62·5% | 83·5% | 21·0% (< 0·01) | 71·2%c | −12·3% (0·05) | 8·7% (0·16) |
RK Khan (ref) | 68·4% | 84·8% | 16·4% (0·03) | 88·3% | 3·5% (0·42) | 19·9% (< 0·01) | |
Mkhuze | 33·9%c | 65·1%c | 31·2% (< 0·01) | 75·8%c | 10·7% (< 0·01) | 41·9% (< 0·01) | |
Shallcross (ref) | 75·6% | 89·4% | 13·8% (< 0·01) | 91·3% | 1·9% (0·34) | 15·7% (0·08) | |
Jozini | 35·3%c | 63·2% | 27·9% (< 0·01) | 72·4%c | 9·0% (0·31) | 37·1% (< 0·01) | |
Township (ref) | 55·4% | 65·7% | 10·3% (< 0·01) | 67·5% | 1·8% (0·34) | 12·1% (0·01) |